NCPW 2025: Fighting against Deceptive Marketing
If you’ve been misled by an ad, regulators want to hear from you. We do too.
Similasan Eye Relief
Case Name (Date)
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Product/Service
Similasan Eye Relief products
Allegations
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Status
Settled
(Preliminarily approved)
https://www.homeopathiceyedropsettlement.com/home
The Latest
Xfinity Home Internet and Mobile Promotion
It’s easier to rack up hidden fees than it is to cancel.
AARP Membership
The only thing more “ridiculous” than the touted benefits is the cancellation process.
Should Movie Theaters Be Required to Advertise Actual Start Times?
Under a proposed bill, theaters could be fined for making moviegoers guess.
1st Phorm’s ‘110% Money-Back Guarantee’
Money-back guarantee comes up woefully short of advertised percentage.